189 related articles for article (PubMed ID: 20037727)
1. Matrix Metalloproteinase-9 (MMP9)-A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders.
Rybakowski JK
Cardiovasc Psychiatry Neurol; 2009; 2009():904836. PubMed ID: 20037727
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-9 gene and bipolar mood disorder.
Rybakowski JK; Skibinska M; Leszczynska-Rodziewicz A; Kaczmarek L; Hauser J
Neuromolecular Med; 2009; 11(2):128-32. PubMed ID: 19536654
[TBL] [Abstract][Full Text] [Related]
3. Increased serum matrix metalloproteinase-9 (MMP-9) levels in young patients during bipolar depression.
Rybakowski JK; Remlinger-Molenda A; Czech-Kucharska A; Wojcicka M; Michalak M; Losy J
J Affect Disord; 2013 Apr; 146(2):286-9. PubMed ID: 22858217
[TBL] [Abstract][Full Text] [Related]
4. Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene and response to lithium prophylaxis in bipolar patients.
Rybakowski JK; Skibinska M; Suwalska A; Leszczynska-Rodziewicz A; Kaczmarek L; Hauser J
Hum Psychopharmacol; 2011 Mar; 26(2):168-71. PubMed ID: 21437990
[TBL] [Abstract][Full Text] [Related]
5. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
6. Functional polymorphism of the matrix metalloproteinase-9 (MMP-9) gene in schizophrenia.
Rybakowski JK; Skibinska M; Kapelski P; Kaczmarek L; Hauser J
Schizophr Res; 2009 Apr; 109(1-3):90-3. PubMed ID: 19264454
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase 9 (MMP9) level and MMP9 -1562C>T in patients with obstructive sleep apnea: a systematic review and meta-analysis of case-control studies.
Fang X; Chen J; Wang W; Feng G; Li X; Zhang X; Zhang Y; Zhang J; Xu Z; Tai J; Ni X
Sleep Med; 2020 Mar; 67():110-119. PubMed ID: 31918116
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix proteins matrix metallopeptidase 9 (MMP9) and soluble intercellular adhesion molecule 1 (sICAM-1) and correlations with clinical staging in euthymic bipolar disorder.
Reininghaus EZ; Lackner N; Birner A; Bengesser S; Fellendorf FT; Platzer M; Rieger A; Queissner R; Kainzbauer N; Reininghaus B; McIntyre RS; Mangge H; Zelzer S; Fuchs D; Dejonge S; Müller N
Bipolar Disord; 2016 Mar; 18(2):155-63. PubMed ID: 27016286
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentration, genetic variation, and gene expression levels of matrix metalloproteinase 9 in Iranian patients with coronary artery disease.
Mahmoodi K; Kamali K; Karami E; Soltanpour MS
J Res Med Sci; 2017; 22():8. PubMed ID: 28400830
[TBL] [Abstract][Full Text] [Related]
10. Functional polymorphism of matrix metalloproteinase-9 (MMP9) gene is not associated with schizophrenia and with its deficit subtype.
Bienkowski P; Samochowiec J; Pelka-Wysiecka J; Grzywacz A; Skibinska M; Jasiewicz A; Tybura P; Wroński M; Jarema M; Samochowiec A
Pharmacol Rep; 2015 Jun; 67(3):442-5. PubMed ID: 25933951
[TBL] [Abstract][Full Text] [Related]
11. MMP9 Promoter Polymorphism (-1562 C/T) Does not Affect the Serum Levels of Soluble MICB and MICA in Breast Cancer.
Bargostavan MH; Eslami G; Esfandiari N; Shams Shahemabadi A
Iran J Immunol; 2016 Mar; 13(1):45-53. PubMed ID: 27026046
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
[TBL] [Abstract][Full Text] [Related]
13. Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population.
Mirowska-Guzel D; Gromadzka G; Czlonkowski A; Czlonkowska A
J Neuroimmunol; 2009 Sep; 214(1-2):113-7. PubMed ID: 19628284
[TBL] [Abstract][Full Text] [Related]
14. Association of MMP9-1562C/T and MMP13-77A/G Polymorphisms with Non-Small Cell Lung Cancer in Southern Chinese Population.
Li W; Jia MX; Wang JH; Lu JL; Deng J; Tang JX; Liu C
Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30889876
[TBL] [Abstract][Full Text] [Related]
15. Biochemical characterization and structure determination of a potent, selective antibody inhibitor of human MMP9.
Appleby TC; Greenstein AE; Hung M; Liclican A; Velasquez M; Villaseñor AG; Wang R; Wong MH; Liu X; Papalia GA; Schultz BE; Sakowicz R; Smith V; Kwon HJ
J Biol Chem; 2017 Apr; 292(16):6810-6820. PubMed ID: 28235803
[TBL] [Abstract][Full Text] [Related]
16. DNA Methylation and Gene Expression of Matrix Metalloproteinase 9 Gene in Deficit and Non-deficit Schizophrenia.
Gao J; Yi H; Tang X; Feng X; Yu M; Sha W; Wang X; Zhang X; Zhang X
Front Genet; 2018; 9():646. PubMed ID: 30619470
[TBL] [Abstract][Full Text] [Related]
17. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.
Hu C; Wang J; Xu Y; Li X; Chen H; Bunjhoo H; Xiong W; Xu Y; Zhao J
Gene; 2013 Mar; 517(1):65-71. PubMed ID: 23313298
[TBL] [Abstract][Full Text] [Related]
18. Arylamine
Li P; Butcher NJ; Minchin RF
Mol Pharmacol; 2019 Nov; 96(5):573-579. PubMed ID: 31444237
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of the plasminogen activation pathway in peripheral blood mononuclear cells in multiple sclerosis: possible pathomechanism of matrix metalloproteinase activation.
Cox MB; Bowden NA; Scott RJ; Lechner-Scott J
Mult Scler; 2013 Sep; 19(10):1268-74. PubMed ID: 23401127
[TBL] [Abstract][Full Text] [Related]
20. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ
Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
